Skip to main content
. 2020 Jul 10;17(14):4985. doi: 10.3390/ijerph17144985

Table 1.

Individual characteristics of the participants (n = 80) in the Baby Machi study by natural conception during 24-weeks follow-up, and any conception (natural or assisted) during 2 year follow up. Median (interquartile range), mean (SD), or n (%).

Variable Total (n = 80) Natural Conception in 24-Weeks Conception in Two-Years 3
No (n = 45) Yes (n = 35) No (n = 17) Yes (n = 59)
Observed Number of Menstrual Cycles 5.0 (2.0, 6.0) 6.0 (5.0, 7.0) 2.0 (1.5, 3.5) - -
Age (Year) 29.5 (2.7) 29.9 (2.8) 28.9 (2.6) 30.4 (2.1) 29.3 (2.9)
Partner’s Age (Year) 31.8 (4.7) 31.9 (5.0) 31.7 (4.4) 32.6 (6.1) 31.1 (3.9)
BMI (kg/m2) 20.8 (2.4) 21.0 (2.0) 20.4 (2.8) 21.5 (2.4) 20.5 (2.4)
15.9–19.4 27 (34%) 12 (27%) 15 (43%) 3 (18%) 23 (39%)
19.4–21.6 26 (33%) 16 (36%) 10 (29%) 6 (35%) 19 (32%)
21.6–28.9 27 (34%) 17 (38%) 10 (29%) 8 (47%) 17 (29%)
DUI (Month) 6 (3, 18) 6 (3, 24) 6 (3, 13) 7 (3, 20) 6 (3, 14)
<12 50 (63%) 25 (56%) 25 (71%) 10 (59%) 38 (64%)
12–23 14 (18%) 5 (11%) 9 (26%) 3 (18%) 11 (19%)
24+ 11 (14%) 10 (22%) 1 (3%) 3 (18%) 6 (10%)
Do not remember 5 (6%) 5 (11%) 0 (0%) 1 (6%) 4 (7%)
Smoking
Never 67 (84%) 39 (87%) 28 (80%) 14 (82%) 50 (85%)
Quit 9 (11%) 4 (9%) 5 (14%) 2 (12%) 7 (12%)
Current 4 (5%) 2 (4%) 2 (6%) 1 (6%) 2 (3%)
Partner’s Smoking
Never 48 (60%) 27 (60%) 21 (60%) 12 (71%) 34 (58%)
Quit 15 (19%) 7 (16%) 8 (23%) 2 (12%) 12 (20%)
Current 17 (21%) 11 (24%) 6 (17%) 3 (18%) 13 (22%)
Gravidity
Gravid 15 (19%) 8 (18%) 7 (20%) 3 (18%) 10 (17%)
Nulligravid 1 65 (81%) 37 (82%) 28(80%) 14 (82%) 49 (83%)
Serum AMH (ng/mL) 5.1 (2.8, 8.0) 5.6 (2.7, 8.6) 4.4 (2.8, 6.8) 5.8 (4.1, 9.3) 4.8 (2.9, 7.7)
dCoital Frequency 2 3.3 (2.5, 8.0) 2.5 (2.5, 4.0) 4.0 (2.5, 8.0) 4.0 (2.5, 8.0) 4.0 (2.5, 8.0)

AMH, antimüllerian hormone. DUI, duration of unprotected intercourse at enrolment. 1 Includes n = 1 participant who reported that she did not know her gravidity status. 2 Per month number of days with sexual intercourse in the past three months, reported at intake. 3 n = 4 women were lost to follow-up.